DAY 1: Monday, July 10, 2017 |
|||
DRUG DISCOVERY & THERAPY WORLD CONGRESS 2017 and Global
Biotechnology Congress 2017 |
|||
TIME |
INAUGURAL
PROGRAM ::: Location: Essex Center ::: 3rd Floor |
||
8:25 - 8:30 am |
Guests to be Seated |
|
|
8:30 - 8:40 am |
Welcome Remarks by Chairmen Organizing Committee |
Prof. Ferid Murad (Nobel Laureate) and Prof. Atta-ur-Rahman, FRS |
|
Chairman: A.D. MacKerell, Jr. Co-Chairman: Atta-ur-Rahman |
JOINT PLENARY
SESSION ::: Location: Essex Center ::: 3rd Floor |
||
Time |
Speakers |
Titles |
|
8:40 - 9:25 am |
Stephen Joseph Elledge PL-1 |
Aneuploidy Promotes Cell Proliferation and Inhibits Immune Surveillance * |
|
9:25 - 10:10 am |
Kenneth Carl Anderson PL-2 |
Targeting Achilles Heels in Myeloma |
|
COFFEE &
SOCIAL MIXER (Location: Essex Foyer – 3rd Floor): 10:10 – 10:40 AM |
|||
Locations |
Lecture Hall St. George A & B 3rd Floor |
Lecture Hall St. George C 3rd Floor |
Lecture Hall St. George D 3rd Floor |
|
Tracks |
Pharmaceutical Research & Development |
Drug Delivery & Targeting |
Plant & Environment |
|
Anti-Infectives |
||||
Translational Medicine |
||||
In-silico Drug Design and In-silico Screening |
||||
Chairman: R. Chaguturu Co-Chairman: C. Gonzalez-Bello |
Chairman: B. Kleuser Co-Chairman: M. Schäfer-Korting |
Chairman: M. Ohme-Takagi Co-Chairman: R. Bensen |
||
10:40 - 11:15 am |
10:40 - 11:10 am |
10:40 - 11:10 am |
||
KNL-3 Rathnam Chaguturu Drug Discovery Efforts Mirror the Proverbial Hyper Cycle: What’s Next? |
IL-4 Monika Schäfer-Korting Rethinking Drug Development – Improving Translational Research |
IL-5 Masaru Ohme-Takagi Negative Regulations Play a Role as “Keystones” for the Control of Physiological Activities in Plants |
||
11:15 - 11:35 am |
11:10 - 11:30 am |
11:10 - 11:30 am |
||
SL-6 Mario Milani The Difficult Path Toward Knowledge: An Ongoing Story on New Dengue Virus Inhibitors |
SL-7 Burkhard Kleuser Crosstalk Between Core-multishell Nanocarriers and Antigen-presenting Cells of the Skin
|
SL-8 Robert Bensen Improving Drought Tolerance in Crop Plants: An Industry Perspective |
||
11:35 - 11:55 am |
11:30 - 11:50 am |
11:30 - 11:50 am |
||
SL-9 Concepción González-Bello Freezing the Essential Motion of Key Bacterial Enzymes – A Strategy for Antibiotic Drug Discovery |
SL-10 Christian Zoschke The Barrier Function of Organotypic Non-melanoma Skin Cancer Models |
SL-11 Tomokazu Kawashima Extended Comparative Genomics to Identify Agriculturally Useful Genes in Plants |
||
11:55 - 12:15 pm |
11:50 - 12:10 pm |
11:50 - 12:10 pm |
||
SL-11(a) Yanxiang Zhao Molecular Mechanism of β-lactamases and Implication for Antibiotic Resistance |
SL-13 Muhammad Qadir Novel Radiolabeled Polydentate Ligands as Potential Diagnostic Probes |
SL-14 Brian Vande Berg Trait Components to Support an Integrated R&D Strategy |
||
12:15 - 12:35 pm |
12:10 - 12:30 pm |
12:10 - 12:30 pm |
||
SL-12 Roman Maciej Kalina Placebo Effect as Starting Point of the Use of Innovative Agonology in the Therapy and Treatment |
SL-16 Ajit Sharma Drug Entrapment in Dendrimers |
SL-17 Masami Yokota Hirai Metabolomics-based Studies for Understanding of Plant Metabolism |
||
12:35 - 12:55 pm |
12:30 - 12:50 pm |
12:30 - 12:50 pm |
||
SL-15 Ravindranath Singh Rathore Novel Dual-binding Cation-π Inhibitors of AChE: Design, Synthesis and Biological Evaluation (Withdrawn) |
SL-18 Eckart Ruehl Topical Drug Delivery into Skin Probed by Label-free Spectromicroscopy |
SL-19 Ling Yuan Plant Genome Editing for the Production of Valuable Proteins |
||
|
12:50 - 1:10 pm |
12:50 - 1:10 pm |
||
|
SL-20 Ulrike Alexiev Advanced Time-resolved Fluorescence Microscopy for Investigating Nanocarrier and Drug Delivery |
SL-20(a) Zhaohua Peng Proteome-wide Analysis of Lysine 2-hydroxyisobutyrylation in Developing Rice (Oryza sativa) Seeds Reveals Unique Sequence Feature of Modification Sites and Functions in Seed Development
|
||
LUNCH BREAK
(Location: Essex South – 3rd Floor): 1:00 – 2:30 PM |
||||
Locations |
Lecture Hall St. George A & B 3rd Floor |
Lecture Hall St. George C 3rd Floor |
Lecture Hall St. George D 3rd Floor |
|
Tracks |
Proteomics & Bioinformatics |
Genomics |
Regenerative Medicine |
|
Recent Advances in Patient Treatment and Care |
||||
Medical Imaging |
Hot Topics in Drug Targets |
|||
Drug Discovery in Preclinical Research |
||||
Biologics |
||||
Chairman: F. Huq Co-Chairman: M. Younus |
Chairman: Van S. Kristel Co-Chairman: H.M. Sobell |
Chairman: I. Roy Co-Chairman: M. Tosun |
||
2:30 - 3:00 pm |
2:30 - 3:00 pm |
2:30 - 3:05 pm |
||
IL-21 Fazlul Huq Tumour Active Phytochemicals Found to Enhance Platinum Action in Ovarian Tumour Models |
IL-22 Henry Martinique Sobell The Centers of Premeltons Signal the Beginning and Ends of Genes |
KNL-23 Ali Khademhosseini Nano- and Microfabricated Hydrogels for Regenerative Engineering |
||
3:00 - 3:20 pm |
3:00 - 3:20 pm |
3:05 - 3:25 pm |
||
SL-24 Yi Zhang In Vivo Imaging of Neuxial Inflammation in Sciatica Pain with PET/MRI |
SL-25 Doris Vandeputte The Gut Microbiome in Health and Disease, The Importance of Quantitative Microbiome Profiling |
SL-26 Nassim Halim Abi Chahine The Regentime Procedure, A Safe Way for Regeneration |
||
3:20 - 3:55 pm |
3:20 - 3:40 pm |
3:25 - 3:45 pm |
||
KNL-27 Muhammad Iqbal Choudhary New Pharmacophores from Medicinal Plants (Withdrawn)
|
SL-28 Van Steen Kristel Systems Genetics for Precision Medicine |
SL-29 Bruno Delorme The Concept of Mesenchymal Stem Cells: From Their Discovery to Innovative MSC-derived Therapies |
||
3:55 - 4:15 pm |
3:40 - 4:00 pm |
3:45 - 4:05 pm |
||
SL-30 Tatsuya Takimoto Study on the Correlation Between Structures of Bithiazole Derivatives and Plasmid DNA Cleavage Activity by Using Simulation and Experiment |
SL-31 Fentaw Abegaz Epistasis Detection for Human Complex Diseases in Structured Populations |
SL-32 Hae Lin Jang An Explanation of the Ratio Between Hydroxyapatite and Whitlockite in Bone: Interplay of the Two Major Nanocrystals for Bone Formation |
||
4:15 - 4:35 pm |
4:00 - 4:20 pm |
4:05 - 4:25 pm |
||
SL-33 Maayan Gal Computational and Biophysical Tools Towards PPIs Drug Discovery
|
SL-34 William Joseph Rowe Neil Armstrong Syndrome and Thermoregulation
|
SL-35 Metiner Tosun Functional Genomics Analysis of Hepatocellular Tumor-initiating Cells |
||
4:35 - 4:55 pm |
4:20 - 4:55 pm |
4:25 - 4:45 pm |
||
SL-36 Muhammad Younus Lead Residues in Lohi Sheep: A Hemato-biochemical and Histopathological Study
|
KNL-37 Simon Christopher Robson The Ectonucleotidase CD39 is a Checkpoint Inhibitor Target in Cancer |
SL-38 Jung Park Electric Field-guided Stem Cell Differentiation on TiO2 Nanotubular Surfaces |
||
COFFEE BREAK
(Location: Essex Foyer – 3rd Floor): 5:00 - 5:30 PM |
||||
DAY 2: Tuesday, July 11, 2017 |
|||
Chairman: I.
Nagy |
JOINT PLENARY
SESSION ::: Location: Essex Center ::: 3rd Floor |
||
Time |
Speakers |
Titles |
|
9:00 - 9:45 am |
PL-39 Shuji Ogino |
Emerging Pharmaco-MPE (Molecular Pathological Epidemiology) and Immuno-MPE For Precision Medicine |
|
9:45 - 10:30 am |
PL-40 Rudolf Jaenisch |
Epigenetics, Stem Cells and Disease Research |
|
COFFEE &
SOCIAL MIXER (Location: Essex Foyer – 3rd Floor): 10:30 - 11:15 AM |
|||
Locations |
Lecture Hall St. George A & B 3rd Floor |
Lecture Hall St. George C 3rd Floor |
Lecture Hall St. George D 3rd Floor |
|
Tracks |
Innovative Drug Discovery and Nanotechnology |
Protein & Peptide Sciences |
Pharmaceutical Biotechnology
|
|
High-throughput Screening & Laboratory Automation |
Industrial and Manufacturing |
|||
Chairman: T.J. Webster Co-Chairman: A. Mazzaglia |
Chairman: E.B. Thompson Co-Chairman: I.J. McEwan |
Chairman: A. Gravanis Co-Chairman: S. Suchkov |
||
11:15 - 11:50 am |
11:15 - 11:45 am |
11:15 - 11:35 am |
||
KNL-41 Thomas Jay Webster The Age of “Nano-biotics”: Self-assembled Materials as Novel Antibacterial Agents Against Drug-resistance Bacteria |
IL-42 Elizabeth Brad Thompson Protein Intrinsic Disorder in Drug Design and Use |
SL-43 Sergey Suchkov 2nd Lecture PM (Personalized Medicine) as a New Model of National and International Healthcare Services to Secure a Biosafety of the Society |
||
11:50 - 12:20 pm |
11:45 - 12:05 pm |
11:35 - 12:05 pm |
||
IL-44 Antonino Mazzaglia Nanomaterials Based on Cyclodextrin: Design, Advances in (Photo) Therapeutics Delivery and Bio-performances |
SL-45 Collin Stultz Dynamics of Alpha-synuclein Aggregation |
IL-46 Achilleas Gravanis Synthetic Microneurotrophins in Brain Protection and Function
|
||
12:20 - 12:40 pm |
12:05 - 12:25 pm |
12:05 - 12:40 pm |
||
SL-47 Keiichi Motoyama Potential Use of Cyclodextrin Derivatives as Therapeutic Agents for Lysosomal Storage Disorders |
SL-48 William Austin Elam A Protein Stabilizing Osmolyte Restores Mutant Glucocorticoid Receptor Binding |
KNL-49 M. Amin Arnaout Structure-based therapeutic Targeting of Integrins (Withdrawn) |
||
12:40 - 1:00 pm |
12:25 - 12:45 pm |
12:40 - 1:00 pm |
||
SL-50 Ravindra Peravali Drug Discovery and Testing Using High-throughput Morphological and Behavioral Screening of Zebrafish Larvae (Withdrawn) |
SL-51 Lidija Covic Pepducins as Allosteric Agents and Therapeutics to Prevent Coronary Artery Thrombosis and NASH
|
SL-52 Weiwen Zhang Synthetic Biology of Photosynthetic Cyanobacteria: Regulation of Tolerance |
||
|
12:45 - 1:05 pm |
|
||
|
SL-53 Iain Joseph McEwan The Intrinsically Disordered Amino Terminal Domain of Steroid Hormone Receptors as a Novel Drug Target: Identification of Small Molecule Inhibitors |
|
||
LUNCH BREAK
(Location: Essex South – 3rd Floor): 1:00 - 2:30 PM |
||||
Locations |
Lecture Hall St. George A & B 3rd Floor |
Lecture Hall St. George C 3rd Floor |
Lecture Hall St. George D 3rd Floor |
|
Tracks |
Innovative Drug Discovery and Nanotechnology |
Protein & Peptide Sciences |
Pharmaceutical Biotechnology
|
|
Chemistry / Combinatorial Chemistry |
Drug Discovery in Preclinical Research |
Plant & Environment |
||
Diabetes and Obesity Drug Discovery and Therapy |
||||
Chairman: K. Motoyama Co-Chairman: G. Gouhier |
Chairman: P.B. Watkins Co-Chairman: I. Nagy |
Chairman: H.-Q. Ling Co-Chairman: J. Nilvebrant |
||
2:30 - 2:50 pm |
2:30 - 2:50 pm |
2:30 - 2:50 pm |
||
SL-54 Géraldine Gouhier Cyclodextrins: An Appropriate Scaffold for New MRI Theranostic Probes |
SL-55 Jing Li Intrinsic Disorder and Allostery in Glucocorticoid Receptor |
SL-56 Johan Nilvebrant Antibody Libraries Based on An Autonomous Human Variable Domain |
||
2:50 - 3:10 pm |
2:50 - 3:10 pm |
2:50 - 3:10 pm |
||
SL-57 Lajos Szente Therapeutic and Diagnostic Utility of Cyclodextrin Derivatives |
SL-58 Raj Kumar Role of Site-specific Phosphorylation in the Action of Glucocorticoid Receptor |
SL-59 Walter Schubert Tissue Worlds2.0: MUS-ICR Robotics Decoding the Dark Space of Diseases-Experience with ALS to Therapy |
||
3:10 - 3:30 pm |
3:10 - 3:30 pm |
3:10 - 3:30 pm |
||
SL-60 Valentina Rapozzi Innovative Drugs in Photodynamic Therapy |
SL-61 Lei Li Discovery and Pharmacological Evaluation of Novel Caeridins with Smooth Muscle Activities, Isolated from the Skin Secretion of the Australian White’s Tree Frog, Litoria caerulea |
SL-62 Sergey Suchkov Antibody-proteases as a Novel Biomarker and Thus the Unique Target to Manage Demyelination: A Green Light to be Opened for Biopharma |
||
3:30 - 3:50 pm |
3:30 - 4:00 pm |
3:30 - 3:50 pm |
||
SL-63 Keiichi Motoyama Mitophagy-mediated Novel Cell Death Induced by Folate-appended Methyl-β-cyclodextrin
|
IL-64 Istvan Nagy Integrated Approach to Identify New Targets for Analgesics for Burn Injury-associated Pain |
SL-65 Leyanis Rodríguez Vera Pharmacometric Approach to Support Dosing Strategy of Nimotuzumab in Patients with Breast Cancer |
||
3:50 - 4:10 pm |
4:00 - 4:20 pm |
3:50 - 4:10 pm |
||
SL-66 José García Suárez Production of a Novel Recombinant Polypeptide from Serratia marcescens for Cancer Therapy |
SL-67 Peter Juhasz Target Discovery from Phenotypic Screens and Known Compounds of Unknown Target |
SL-68 Evan Bennett Siegel Advancing New Biotechnology Products into Clinical Trials and Marketing Applications |
||
4:10 - 4:30 pm |
4:20 - 4:40 pm |
4:10 - 4:40 pm |
||
SL-69 Mostafa Mostafa Abo Elsoud Effect of Gamma Irradiation on Biogenic Production of Tellurium Nanoparticles (Withdrawn) |
SL-70 Sini Junttila Bioinformatic Next Generation Sequencing Data Analysis Workflow for Preclinical Studies |
IL-71 Hong-Qing Ling Molecular Regulation Mechanisms of Iron Uptake and Homeostasis in Plants |
||
4:30 - 4:50 pm |
4:40 - 5:00 pm |
4:40 - 5:00 pm |
||
SL-72 Shamshad Begum Quraishi A New Approach for Diagnosis of Wilson’s Disease and Bangladesh Perspective |
SL-73 Paul B. Watkins Using Quantitative Systems Toxicology (QST) to Assess Drug Safety: The Experience of the DILIsim Initiative |
SL-74 Junhua Peng Solar Radiation and Adaptive Genetic Differentiation in Wild Emer Wheat, Triticum dicoccoides |
||
4:50 - 5:10 pm |
5:00 - 5:20 pm |
5:00 - 5:20 pm |
||
SL-75 Ying Wang Chemistry in the Fast Lane-enabling Technologies for Drug Discovery |
SL-76 Laszlo Urban Translational Aspects of Secondary Pharmacology |
SL-77 Huixia Shou Regulation of Phosphate Homostasis via the Ubiquitin-conjugating E2 Enzyme, PHO2 and a RING-type E3 Ubiquitin-ligase, OsNLA1 in Rice |
||
5:10 - 5:30 pm |
5:20 - 5:40 pm |
5:20 - 5:40 pm |
||
SL-78 Maria Grishina www.ChemoSophia.com On-line Computational Services for In silico Drug Design and Screening |
SL-79 Graham Dempsey All-optical Electrophysiology for Neuroscience and Cardiovascular Drug Discovery |
SL-80 Qian-Hua Shen Barley Interaction with Powdery Mildew Fungus: How Protein Kinases Regulate Defense Transcriptions |
||
5:30 - 5:50 pm |
|
|||
SL-81 Tarek Mahmoud Mahfouz Small Molecule Affinities for Sirt-1 Deacetylase Enzyme |
|
|||
COFFEE BREAK
(Location: Essex Foyer – 3rd Floor): 5:30 - 6:00 PM |
||||
DAY 3: Wednesday, July 12, 2017 |
||
Chairman: R. Chaguturu |
JOINT PLENARY SESSION ::: Location: Essex Center ::: 3rd Floor |
|
Time |
Speakers |
Titles |
9:00 - 9:45 am |
PL-82 Ferid Murad (Nobel Laureate) |
Application of Nitric Oxide Research to Drug Development
|
9:45 - 10:30 am |
PL-83 Alexander D. MacKerell, Jr. |
Can CADD Drive Drug Design and Development? Rapid Estimation of Relative Binding Affinities Based on Pre-Computed Ensembles |
10:30 - 11:15 am |
PL-84 D.K. Lahiri |
Role of Non-coding RNAs in Alzheimer’s Disease |
POSTER
SESSION: 11:15 – 12:15 PM: (Location: Essex North West & Center – 3rd
Floor) LUNCH
BREAK: 12:15 – 1:15 PM: (Location: Essex South – 3rd Floor) |
DAY 4: Thursday, July 13, 2017 |
||
Chairman: R.
Kumar |
JOINT PLENARY
SESSION ::: Location: Essex Center ::: 3rd Floor |
|
Time |
Speakers |
Titles |
9:00 - 9:45 am |
PL-121 Vladimir Torchilin |
Stimuli-sensitive Multifunctional Combination Nanopreparations of siRNA and Chemotherapeutic Drugs to Treat Multidrug Resistant Cancer |
9:45 - 10:30 am |
PL-122 Steven A. Carr |
Quantitative Proteomics in Biology, Chemistry and Medicine |
10:30 - 11:15 am |
PL-123 Stuart L. Schreiber
|
Chemistry Towards Novel Mechanism-of-action Compounds in Therapeutics Discovery |
POSTER
SESSION: 11:15 – 12:15 PM: (Location: Essex North West & Center – 3rd
Floor) LUNCH BREAK:
12:15 – 1:15 PM: (Location: Essex South – 3rd Floor) |